Abiopharma

🔍 Okupe Oluyemi (Executive)

Company: Hims & Hers Health, Inc. (HIMS)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 4,938 shares of Class A Common Stock at $5.01 per share (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 269,055.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 4,938 shares of Class A Common Stock at $29.9942 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 264,117.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-19 | Code: H | nature_of_ownership: Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021 | shares_owned_after: 7,853.00
• Sold 4,938 shares of Stock Option (right to buy) at $5.01 per share (Derivative)
  Date: 2026-08-19 | Code: M | Expires: 2032-02-23 | equity_swap_involved: 0 | shares_owned_after: 80,872.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
• F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.0450. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
• F3: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.